Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma.
- DOI
- 10.1016/j.jtocrr.2024.100779
- Published
- 2025 Mar
- Container
- JTO clinical and research reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtocrr.2024.100779,
title = {Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma.},
author = {Uehara Y and Izumi H and Taki T and Sakai T and Udagawa H and Sugiyama E and Umemura S and Zenke Y and Matsumoto S and Yoh K and Kubota S and Aokage K and Sakamoto N and Sakashita S and Kojima M and Nagamine M and Hosomi Y and Tsuboi M and Goto K and Ishii G},
year = {2025},
journal = {JTO clinical and research reports},
doi = {10.1016/j.jtocrr.2024.100779},
url = {https://doi.org/10.1016/j.jtocrr.2024.100779}
}RIS
TY - JOUR TI - Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma. AU - Uehara Y AU - Izumi H AU - Taki T AU - Sakai T AU - Udagawa H AU - Sugiyama E AU - Umemura S AU - Zenke Y AU - Matsumoto S AU - Yoh K AU - Kubota S AU - Aokage K AU - Sakamoto N AU - Sakashita S AU - Kojima M AU - Nagamine M AU - Hosomi Y AU - Tsuboi M AU - Goto K AU - Ishii G PY - 2025 JO - JTO clinical and research reports DO - 10.1016/j.jtocrr.2024.100779 UR - https://doi.org/10.1016/j.jtocrr.2024.100779 ER -
APA
Y, U., H, I., T, T., T, S., H, U., E, S., S, U., Y, Z., S, M., K, Y., S, K., K, A., N, S., S, S., M, K., M, N., Y, H., M, T., K, G., & G, I. (2025). Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2024.100779
Source records
- pubmed · retrieved 2026-09-26T06:46:46.664Z